THE DEFINITIVE GUIDE TO BLUE CAPSULE TABLET

There was no one adverse reaction leading to discontinuation that transpired in a rate of >two% in CAPLYTA-addressed patients.Counsel relations or caregivers of individuals to watch for adjustments in behavior and to notify the healthcare provider. Look at modifying the therapeutic program, like probably discontinuing CAPLYTA, in clients whose desp